Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiji Yamamoto

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 15, 2010
[Nonclinical prediction and clinical evaluation of drug-induced QT prolongation]Keiji Yamamoto
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 27, 2007
Synchronicity and ventricular arrhythmias in hypertensionKeiji Yamamoto
Nihon Hoshasen Gijutsu Gakkai Zasshi|July 5, 2005
[CAD for digital chest radiograph]Keiji Yamamoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 17, 2007
[Pharmacology studies]Keiji Yamamoto
Current Vascular Pharmacology|August 24, 2004
Role of mechanical stress in monocytes/macrophages: implications for atherosclerosisKeiji Yamamoto, Uichi Ikeda, Kazuyuki Shimada
Chemical & Pharmaceutical Bulletin|February 8, 2011
Analysis of molecular interactions in solid dosage forms; challenge to molecular pharmaceuticsKeiji Yamamoto, Waree Limwikrant, Kunikazu Moribe
Advanced Drug Delivery Reviews|November 17, 2007
Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formationKunikazu Moribe, Yuichi Tozuka, Keiji Yamamoto
Pharmaceutical Research|June 24, 2003
Adsorption and entrapment of salicylamide molecules into the mesoporous structure of folded sheets mesoporous material (FSM-16)Yuichi Tozuka, Toshio Oguchi, Keiji Yamamoto
Pharmaceutical Research|January 14, 2003
Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of beta-cyclodextrin anhydrate and hydrateArpansiree Wongmekiat, Yuichi Tozuka, Toshio Oguchi, et al.
Atherosclerosis|September 5, 2002
Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cellsTakayuki Ito, Uichi Ikeda, Keiji Yamamoto, et al.
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 15, 2010
[Nonclinical prediction and clinical evaluation of drug-induced QT prolongation]Keiji Yamamoto
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 27, 2007
Synchronicity and ventricular arrhythmias in hypertensionKeiji Yamamoto
Nihon Hoshasen Gijutsu Gakkai Zasshi|July 5, 2005
[CAD for digital chest radiograph]Keiji Yamamoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 17, 2007
[Pharmacology studies]Keiji Yamamoto
Current Vascular Pharmacology|August 24, 2004
Role of mechanical stress in monocytes/macrophages: implications for atherosclerosisKeiji Yamamoto, Uichi Ikeda, Kazuyuki Shimada
Chemical & Pharmaceutical Bulletin|February 8, 2011
Analysis of molecular interactions in solid dosage forms; challenge to molecular pharmaceuticsKeiji Yamamoto, Waree Limwikrant, Kunikazu Moribe
Advanced Drug Delivery Reviews|November 17, 2007
Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formationKunikazu Moribe, Yuichi Tozuka, Keiji Yamamoto
Pharmaceutical Research|June 24, 2003
Adsorption and entrapment of salicylamide molecules into the mesoporous structure of folded sheets mesoporous material (FSM-16)Yuichi Tozuka, Toshio Oguchi, Keiji Yamamoto
Pharmaceutical Research|January 14, 2003
Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of beta-cyclodextrin anhydrate and hydrateArpansiree Wongmekiat, Yuichi Tozuka, Toshio Oguchi, et al.
Atherosclerosis|September 5, 2002
Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cellsTakayuki Ito, Uichi Ikeda, Keiji Yamamoto, et al.
Pageof 19